首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 93 毫秒
1.
为研究硒化壳聚糖对NB4细胞的凋亡及周期阻断作用,用流式细胞法观察了药物对细胞的诱导凋亡及周期阻断作用。结果表明,硒化壳聚糖作用NB4细胞24 h,可剂量依赖性地诱导细胞凋亡并使G0—G1期细胞增多。提示硒化壳聚糖可诱导细胞凋亡,并对NB4细胞周期有特异性阻断作用。  相似文献   

2.
壳聚糖作为药物缓释载体的研究进展   总被引:2,自引:0,他引:2  
壳聚糖作为药物缓释载体在减少给药次数,降低药物毒副作用,提高药物疗效等方面具有重要作用。本文综述了壳聚糖作为药物缓释载体的研究进展,主要包括壳聚糖纳米粒子、微球、片、膜和凝胶等的制备和缓释特性,并对其发展趋势进行了展望。  相似文献   

3.
聚乙二醇-g-壳聚糖可以作为抗肿瘤药物、基因、多肽等多种生物大分子的载体,是一种优良的药物载体。聚乙二醇接枝壳聚糖可以改善壳聚糖的水溶性,保护聚乙二醇-g-壳聚糖纳米不被网状内皮系统(RES系统)识别和清除,促进纳米粒子在体内的长循环,将药物更有效地靶向目标组织。目前,聚乙二醇-g-壳聚糖作为药物载体在生物医药领域发挥着重要作用,本文就聚乙二醇-g-壳聚糖的特点,以及在机体的靶向性、缓释等提高药物疗效的关键因素做一论述。  相似文献   

4.
壳聚糖纳米复合材料   总被引:2,自引:0,他引:2  
壳聚糖纳米材料成为近年研究的热点,随着研究的不断深入,众多的壳聚糖纳米复合材料也应运而生.由于这类材料的制备与复合作用有关,因此在研究与开发阶段进行形成壳聚糖纳米复合材料的物理(或化学)作用的研究具有重要的意义.本文归纳总结了近年来国内外壳聚糖纳米复合材料研究现状和发展趋势,讨论了静电作用、共价交联作用、吸附作用和氢键作用多种复合方式以及复合材料在各个领域中的应用.目前这类材料由于其优越的生物相容性主要用于药物载体.  相似文献   

5.
制备了一类可生物降解肝素钠两性壳聚糖复合物(HPACS),并探索将其用于蛋白药物pH响应释放.两性壳聚糖由壳聚糖与丙烯酸加成反应得到,丙烯酸取代度可通过丙烯酸壳聚糖投料比调控;用胶体与pH浊度滴定研究了肝素钠与两性壳聚糖的复合作用,发现两组分在一定pH范围内能通过静电相互作用形成复合物,复合转变临界pH(pHΦ)与两性壳聚糖中丙烯酸取代度有关,取代度越低,pHΦ值越高.以牛血清白蛋白(BSA)为模型,测定了其在复合物中包埋及不同pH介质中的释药行为.结果表明,BSA可以在非常温和条件下有效包埋于复合物中,包埋率接近100%;BSA从复合物中释放具有很高的pH响应性,释放转变在很窄的pH范围内(<0.4pH单位)完成,释放转变临界pH(pH′Φ)可由两性壳聚糖中丙烯酸取代度调控.复合物形成和蛋白质释放在对pH依赖性上存在很好的相关性.同时还发现,在中性介质中(pH7.4),复合物对BSA具有很好的缓释作用,BSA持续释放时间可达15天左右.  相似文献   

6.
以乙二醇壳聚糖为原料,乙酸酐为酰化剂,通过N-乙酰化反应,制得了新型温敏性高分子乙酰化乙二醇壳聚糖.通过核磁共振氢谱(1H NMR)、傅里叶变换红外光谱(FTIR)及试管倒置法对乙酰化乙二醇壳聚糖的结构及温敏性进行了表征,通过扫描电子显微镜(SEM)和紫外-可见分光光度计(UV-Vis)对水凝胶的微观形貌和体外药物释放性能进行了研究.结果表明,随着反应时间和乙酸酐与乙二醇壳聚糖氨基摩尔比的增加,产物的乙酰度逐渐增加;乙酰化乙二醇壳聚糖溶液具有热可逆温敏性溶胶-凝胶转变行为,可以通过控制乙酰化乙二醇壳聚糖的乙酰度和溶液浓度,使溶胶-凝胶转变温度处于室温至体温(25~37℃)之间;乙酰化乙二醇壳聚糖水凝胶具有"高度孔隙化且孔隙之间相互连通"的结构特点,通过控制乙酰度和溶液浓度,可使其孔径大小处于1~40μm范围内;乙酰化乙二醇壳聚糖水凝胶的乙酰度为89.90%时,质量分数为5%~7%的水凝胶对抗癌药物吉西他滨具有缓释作用,载药凝胶的释药时间可达3~5 d.乙酰化乙二醇壳聚糖有望在药物释放及组织工程等领域得到广泛应用.  相似文献   

7.
歧化松香胺-壳聚糖缀合物的合成、表征及药控缓释行为   总被引:1,自引:1,他引:0  
以天然可再生资源壳聚糖和歧化松香胺为原料,经由苯甲醛保护氨基的Schiff碱壳聚糖,通过环氧氯丙烷搭桥生成具有环氧活性基的壳聚糖,再与歧化松香胺发生接枝反应,首次合成了一种新型壳聚糖衍生物--歧化松香胺-壳聚糖缀合物(DRACC),通过FT-IR、UV、1H-NMR、XRD、SEM和TG-DTA等测试手段对产物进行了分析和表征.由元素分析法测得DRACC的取代度为0.506.并分别以壳聚糖和DRACC作为药物非诺洛芬钙缓释制剂的载体,研究了其在人工肠液和人工胃液中的缓释性能.结果表明,DRACC载体在人工肠液和人工胃液中均具有良好的缓释作用.  相似文献   

8.
接枝壳聚糖在药学领域的应用   总被引:2,自引:0,他引:2  
壳聚糖无毒、具有良好的生物相容性、可生物降解性、无免疫反应和无致癌性等优点,可安全可靠地用于药物中.可是壳聚糖仅溶解在少数稀酸中,从而限制了其广泛的应用.对壳聚糖进行接枝,可使其溶解性增加,或增加一些其它性能,扩大其应用范围.本文从接枝聚合方法和应用的角度,综述了近年来壳聚糖的接枝共聚产物在药学领域的研究进展,包括:聚丙烯酸类、丙烯酰胺类、乙烯基类、聚乙二醇类、聚丙交酯(聚乳酸)类、脂肪酸类、具特殊功能的分子和其它疏水性侧链等,并提出未来的发展方向.  相似文献   

9.
以自制阿司匹林为药物模型,壳聚糖(CS)为载体源,采用微乳液成核-离子交联法制备了阿司匹林/壳聚糖纳米缓释微球.分别用傅里叶变换红外(FTIR)光谱、场发射扫描电子显微镜(FESEM)、透射电子显微镜(TEM)、动态激光光散射(DLLS)、X射线粉末衍射(XRD)等表征了纳米微粒的化学组成、外观形貌、平均粒径和粒径分布、微球中壳聚糖的晶体结构以及阿司匹林的分布形态.结果表明,利用微乳液成核-离子交联法制备的阿司匹林/壳聚糖微球平均粒径约为88nm且粒径分布均匀,成核后壳聚糖结晶形态基本未变,阿司匹林以分子形态分布于微粒中,分子间未形成堆砌,为无定形态.采用UV-Vis分光光度计考察了微球的药物包封率、载药量,并对微球在生理盐水和葡萄糖溶液中的释药行为进行跟踪.结果表明,微球的载药量可达55%,药物包封率可达42%,实验条件下具有较好的药物缓释作用.  相似文献   

10.
利用简单的溶液插层法制备了羧甲基壳聚糖/有机累托石纳米复合材料,其中累托石(REC)用十六烷基三甲基溴化铵进行改性.用X-射线衍射(XRD)、红外光谱(FTIR)和扫描电镜(SEM)表征了该纳米复合材料的微观结构和形态,实验表明羧甲基壳聚糖插层进入了累托石层间,增大了累托石的层间距,并且累托石均匀地分布在羧甲基壳聚糖基体中.以牛血清蛋白(BSA)为药物模型,研究了纳米复合材料与海藻酸钠形成的微球的药物缓释性能.结果显示,该微球对药物的包封率及缓释性能与纯羧甲基壳聚糖微球相比都有较大改善,包封率从56%提高到86%,药物缓释时间从24 h上升到72 h.并且纳米复合材料/海藻酸钠微球的释药具有pH响应性,在pH为1.2的条件下释药慢,而在pH为7.4时释药快,可用于小肠或结肠定位缓释系统.因此,羧甲基壳聚糖/有机累托石纳米复合材料很有潜力作为药物载体.  相似文献   

11.
In recent years, chitosan nanocapsules have shown promising results as carriers for oral drug or peptide delivery. The success in their applicability strongly depends on the stability of these colloidal systems passing through the digestive tract. In gastric fluids, clear stability comes from the high surface charge density of the chitosan shell, which is completely charged at acidic pH values. However, in the intestinal fluid (where the pH is almost neutral) the effective charge of these nanocapsules approaches zero, and the electrostatic forces cannot provide any stabilization. Despite the lack of surface charge, chitosan nanocapsules remain stable in simulated intestinal fluids. Recently, we have demonstrated that this anomalous stability (at zero charge) is owed to short-range repulsive forces that appear between hydrophilic particles when immersed in saline media. The present work examines the influence of the chitosan hydrophobicity, as well as molecular weight, in the stability of different chitosan nanocapsules. A study has been made of the size, polydispersity, electrophoretic mobility, and colloidal stability of eight core-shell nanocapsule systems, in which the chitosan-shell properties have been modified using low-molecular-weight (LMW) and high-molecular-weight (HMW) chitosan chains having different degrees of acetylation (DA). With regard to the stability mediated by repulsive hydration forces, the LMW chitosan provided the best results. In addition, contrary to initial expectations, greater stability (also mediated by hydration forces) was found in the samples formed with chitosan chains of high DA values (i.e. with less hydrophilic chitosan). Finally, a theoretical treatment was also tested to quantify the hydrophilicity of the chitosan shells.  相似文献   

12.
In our previous study, chitosan–alginate microcapsules were developed to protect egg yolk immunoglobulin (IgY) from gastric inactivation. The present study was undertaken to determine the effect of chitosan concentration (0–0.8%; w/v) on various properties of the microcapsules in order to produce the optimum chitosan–alginate microcapsules for use in the oral delivery of IgY. The properties investigated included microcapsule morphology, loading capacity for IgY (expressed as the IgY loading percentage, w/w, of microcapsules), encapsulation efficiency (EE%), in vitro gastroresistance, and IgY release. IgY loading percentage and EE% were both highest at 0.2% (w/v) chitosan, and, above this level, further increases were not observed. The stability of IgY in simulated gastric fluid (pH 1.2) was significantly improved by encapsulation in alginate microcapsules (IgY retained 43.5% of its activity) and was further improved by including chitosan at any of the chitosan concentrations assessed (IgY retained an average of 69.4% activity) although there was no difference in protection of gastric inactivation among concentrations of chitosan varying from 0.05% to 0.8% (w/v). Higher chitosan concentrations (i.e., ≥0.2%; w/v) prolonged the release of IgY from the microcapsules during simulated intestinal fluid incubation (pH 6.8). However, above the 0.2% (w/v) level, no significant differences were observed. We conclude that the optimum chitosan concentration for microencapsulation is 0.2% (w/v).  相似文献   

13.
The carrot plant (Daucus carota) and its components are traditionally reported for the management of gastric ulcers. This study was performed to evaluate the role of carrot when administered concurrently with a conventional antiulcer treatment, pantoprazole, in alleviating gastric and duodenal ulcers in female experimental animals. The study involved standard animal models to determine the ulcer preventive effect using pylorus ligation, ethanol, and stress induced acute gastric ulcer models and duodenal ulcer models involving cysteamine. Acetic acid-induced chronic gastric ulcer and indomethacin-induced gastric ulcer models were used to evaluate the ulcer healing effect. Carrot fruit (500 mg/kg) and its co-administration with pantoprazole produced significant protection in an ethanol- and stress-induced acute gastric ulcer and cysteamine-induced duodenal ulcer. The healing of the acetic acid-induced chronic gastric ulcer was also augmented with this combination. Both total proteins and mucin contents were significantly increased in indomethacin-induced gastric ulcers. Similarly, in pylorus ligation, the pepsin content of gastric juice, total acidity, and free acidity were reduced. Overall, both ulcer preventive effects and ulcer healing properties of the pantoprazole were significantly enhanced in animals who received the co-administration of carrot fruit (500 mg/kg).  相似文献   

14.
Thiazolidinone derivatives (TDCs) were prepared by converting chitosan into chitosan's Schiff's bases (CSBs), followed by treatment with mercaptoacetic acid. Both CSBs and TDCs were tested for antimicrobial activity against four different bacteria. All TDCs showed comparatively better anti-microbial activity without much affecting basic physical properties of chitosan such as film-forming capacity, tensile strength, etc. This indicates that chitosan derivatives with a thiazolidinone moiety might be a better material for wound dressing.  相似文献   

15.
应用壳聚糖-海藻酸盐微囊技术制备了一系列胰岛素微囊,并研究了不同反应条件如海藻酸钠浓度、壳聚糖浓度、壳聚糖分子量及壳聚糖溶液pH值对微囊的胰岛素包封率及其释放性能的影响。结果表明,海藻酸钠浓度越高,微囊对胰岛素的包封率越高,在模拟小肠液中释放速率越低;壳聚糖浓度越大,微囊的胰岛素包封率及其在模拟胃液中释放率越高,在模拟肠液中释放达最大值所需时间越长;而随壳聚糖分子量减小,微囊在胃液中释放率增高;壳聚糖溶液pH值的变化对微囊的胰岛素包封率未造成明显影响。  相似文献   

16.
The natural rubber latex (NRL) film taken from medical surgical gloves was surface-modified with a dielectric barrier discharge (DBD) plasma treatment under an air environment. The results showed that surface hydrophilicity of the NRL film increased after the plasma treatment due to the presence of oxygen-containing polar groups on the plasma-treated surface. An increase in plasma treatment time increased the surface roughness of the NRL film, and eventually decreased the mechanical properties. From the obtained results, the optimum plasma treatment time of 20?s was chosen. After immersion in a chitosan solution, the amount of chitosan deposited on the plasma-treated NRL film increased with increasing chitosan concentrations. The chitosan coating smoothed the surface of the plasma-treated NRL film and also improved the mechanical properties. The highest antibacterial activities of the chitosan-coated DBD plasma-treated NRL film against both Staphylococcus aureus and Escherichia coli were achieved when a 2?%(w/v) chitosan solution was used for the coating.  相似文献   

17.
In this work, the solution plasma process (SPP) is used to treat β-chitosan solutions in order to induce the degradation of chitosan. The effects of solution plasma on the properties of chitosan solutions are investigated. The treatment time was varied from 0 to 300 min. The plasma-treated chitosan was characterized by the following methods; molecular weight by GPC, viscosity, crystal structure by XRD, chemical characteristics by FT-IR, solubility by UV–vis spectrophotometer, and fractional analysis. The results showed that after treatment with plasma for 15–120 min, the viscosity of the chitosan solution and apparent molecular weight of chitosans decreased remarkably, when compared to those of untreated sample. Longer treatment times had less effect on both viscosity and molecular weight of the samples. This suggested that the degradation process of chitosan occurred during plasma treatment. The XRD analysis showed that the crystallinity of chitosan was destroyed, resulting in amorphous structure. FT-IR analysis revealed that chemical structure of chitosan was not affected by solution plasma treatment. The %yield of water-soluble chitosan was increased with increasing plasma treatment time. These results implied that solution plasma process is able to induce the degradation of chitosan solutions.  相似文献   

18.
The thermal and mechanical properties of collagen/chitosan blends before and after UV irradiation have been investigated using thermal analysis and mechanical (Instron) techniques. Comparisons were made with the thermal and mechanical properties of both collagen and chitosan films. Air-dried collagen, chitosan and collagen/chitosan films were exposed to UV irradiation (wavelength 254 nm) for different time intervals. Thermal properties of collagen/chitosan blends depend on the composition of the blend and are not significantly altered by UV irradiation.Mechanical properties such as ultimate tensile strength and ultimate percentage of elongation were much better for collagen films than for collagen/chitosan films. The results have shown that the mechanical properties of the blends were greatly affected by the duration of UV irradiation. Ultimate tensile strength and ultimate percentage elongation decreased after UV irradiation of the blend. Increasing UV irradiation leads to an increase in Young's modulus of the collagen/chitosan blend.  相似文献   

19.
Literature on the modification of the natural polymer chitosan using high-energy chemistry methods (treatment by a low-temperature plasma, with an electron beam, energetic ions, or γ-iradiation) has been surveyed. The basic chitosan treatment procedures and facilities used in the processes have been described. The instrumental techniques used to study changes in the chemical structure and properties of modified chitosan have been considered. Data showing the possibility of using modified chitosan in medicine and biotechnology have been presented.  相似文献   

20.
In this study, nitrogen-plasma treatment was used to enhance the coating of chitosan onto cotton fabric and chlorine was introduced into nitrogen-containing groups on the chitosan coated fabric in order to make it antimicrobial by chlorination with sodium hypochlorite. The antimicrobial property and its rechargeability were investigated. FTIR, UV and scanning electron microscope were used to evaluate the surface properties, including the existence of chitosan on cotton fabric, the content of chitosan on cotton fabric and the surface topography of cotton fabric after modification. The results showed that nitrogen-plasma introduces nitrogen-containing groups into cotton fabric, the coating of chitosan on fabric was improved with nitrogen plasma treatment and chlorine was introduced into the chitosan coated fabric successfully which inhibits bacteria effectively and it is rechargeable. Thus, the antimicrobial property of cotton fabric coated with chitosan with the aid of nitrogen-plasma treatment after chlorination achieved good effects.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号